Bruker Corporation $BRKR Shares Acquired by Public Employees Retirement System of Ohio

Public Employees Retirement System of Ohio increased its stake in shares of Bruker Corporation (NASDAQ:BRKR) by 38.7% during the first quarter, HoldingsChannel.com reports. The institutional investor owned 107,067 shares of the medical research company’s stock after acquiring an additional 29,892 shares during the period. Public Employees Retirement System of Ohio’s holdings in Bruker were worth $3,867,000 as of its most recent filing with the Securities & Exchange Commission.

Other institutional investors have also recently added to or reduced their stakes in the company. Orbis Allan Gray Ltd lifted its position in Bruker by 5.4% during the 4th quarter. Orbis Allan Gray Ltd now owns 14,906,730 shares of the medical research company’s stock worth $702,256,000 after acquiring an additional 761,258 shares during the period. State Street Corp increased its holdings in shares of Bruker by 2.5% in the fourth quarter. State Street Corp now owns 3,831,814 shares of the medical research company’s stock valued at $180,700,000 after purchasing an additional 91,706 shares during the period. AQR Capital Management LLC increased its holdings in shares of Bruker by 125.3% in the second quarter. AQR Capital Management LLC now owns 3,326,820 shares of the medical research company’s stock valued at $137,065,000 after purchasing an additional 1,850,215 shares during the period. Sculptor Capital LP raised its stake in shares of Bruker by 18.3% during the second quarter. Sculptor Capital LP now owns 3,074,801 shares of the medical research company’s stock worth $126,682,000 after purchasing an additional 476,363 shares during the last quarter. Finally, Price T Rowe Associates Inc. MD raised its stake in shares of Bruker by 2,963.4% during the fourth quarter. Price T Rowe Associates Inc. MD now owns 2,366,520 shares of the medical research company’s stock worth $111,488,000 after purchasing an additional 2,289,269 shares during the last quarter. Institutional investors and hedge funds own 79.52% of the company’s stock.

Bruker Price Performance

NASDAQ:BRKR opened at $64.34 on Friday. Bruker Corporation has a 12-month low of $28.53 and a 12-month high of $64.54. The firm has a market cap of $9.79 billion, a price-to-earnings ratio of -268.08, a price-to-earnings-growth ratio of 1.98 and a beta of 1.29. The company’s 50-day moving average is $57.81 and its two-hundred day moving average is $46.54. The company has a current ratio of 1.55, a quick ratio of 0.72 and a debt-to-equity ratio of 0.67.

Bruker (NASDAQ:BRKR) last issued its quarterly earnings results on Wednesday, May 6th. The medical research company reported $0.31 EPS for the quarter, topping analysts’ consensus estimates of $0.23 by $0.08. The business had revenue of $823.40 million during the quarter, compared to the consensus estimate of $795.62 million. Bruker had a negative net margin of 0.65% and a positive return on equity of 11.60%. The company’s quarterly revenue was up 2.7% compared to the same quarter last year. During the same period in the previous year, the firm posted $0.47 earnings per share. Bruker has set its FY 2026 guidance at 2.100-2.150 EPS. Research analysts expect that Bruker Corporation will post 2.12 EPS for the current year.

Bruker Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Tuesday, July 7th. Shareholders of record on Monday, June 22nd were paid a dividend of $0.05 per share. This represents a $0.20 dividend on an annualized basis and a dividend yield of 0.3%. The ex-dividend date of this dividend was Monday, June 22nd. Bruker’s dividend payout ratio is currently -83.33%.

Analyst Ratings Changes

A number of research firms recently weighed in on BRKR. Weiss Ratings upgraded shares of Bruker from a “sell (d)” rating to a “sell (d+)” rating in a research report on Wednesday, June 3rd. TD Cowen restated a “hold” rating on shares of Bruker in a research note on Wednesday, July 15th. Stifel Nicolaus set a $45.00 target price on shares of Bruker in a report on Friday, May 8th. UBS Group set a $60.00 price target on shares of Bruker in a research note on Wednesday, June 24th. Finally, Wall Street Zen raised shares of Bruker from a “hold” rating to a “buy” rating in a report on Saturday, May 9th. One investment analyst has rated the stock with a Strong Buy rating, seven have given a Buy rating, six have assigned a Hold rating and two have given a Sell rating to the stock. According to data from MarketBeat, Bruker has an average rating of “Hold” and an average price target of $56.79.

Bruker Company Profile

Bruker Corporation, founded in 1960 by physicist Günther Laukien and headquartered in Billerica, Massachusetts, is a leading developer and manufacturer of high-performance scientific instruments and analytical solutions. The company designs systems that enable molecular and materials research across academic, governmental, and industrial laboratories.

Bruker’s product portfolio encompasses nuclear magnetic resonance (NMR) spectrometers for molecular structure and dynamics studies, mass spectrometry platforms for proteomics and metabolomics, X-ray diffraction and scattering instruments for crystallography and materials characterization, atomic force and scanning probe microscopes for nanoscale surface analysis, as well as preclinical imaging systems such as micro-CT and MRI scanners.

In addition to hardware, Bruker provides software suites, applications support, training services, and long-term maintenance agreements to ensure optimal instrument performance.